Linda Lennox, who directed IR and corporate communications at Lantheus Medical Imaging, has moved to Massachusetts-based drug company AMAG Pharmaceuticals as VP of IR and corporate comms.

Lennox takes a role held by Kathryn Payne, an APCO Worldwide alum who was upped to VP of external affairs to oversee PR, policy and advocacy at the state and national level.

AMAG focuses on drugs for maternal health, anemia and cancer care and counts Ferumoxytol, an iron deficiency treatment for kidney disease patients, as its flagship. The company, which went public in 2011, this month raised $201M in a public offering. Revenues for 2014 were $124.4M.

Lennox previously led investor and media relations at Critical Therapeutics and held IR and comms. roles at NUI Corp. and Providence Entergy Corp.